Names are a starting point. Evidence is the next step.
Compound Library
Find a name, follow its sources, and keep the limits of what is known in view.
69 names in the index
5-Amino-1MQ
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Abaloparatide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Adamax
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Adipotide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →AHK-Cu
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →AICAR
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →AOD-9604
SOURCE NOTE
FDA notes limited safety information and potential immune-reaction risks.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →ARA-290
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →BPC-157
SOURCE NOTE
FDA highlights limited safety information and potential immune-reaction risks.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Bronchogen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Cagrilintide
SOURCE NOTE
FDA states cagrilintide has not been found safe and effective for any condition.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Cardiogen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Cartalax
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Cerebrolysin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Chonluten
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →CJC-1295 DAC
SOURCE NOTE
FDA reports serious adverse events associated with CJC-1295; clinical data are limited.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →CJC-1295 No DAC
SOURCE NOTE
Check molecular identity carefully; FDA’s CJC-1295 notice is not evidence for every similarly named product.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Cortagen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →DSIP
SOURCE NOTE
FDA lists emideltide (DSIP) with safety-data limitations.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Eloralintide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Epitalon
SOURCE NOTE
FDA describes missing safety information for the proposed route.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →FOXO4-DRI
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →GHK-Cu
SOURCE NOTE
FDA identifies limited human safety data for injectable GHK-Cu.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →GHRP-2
SOURCE NOTE
FDA identifies safety concerns for injectable and nasal administration.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →GHRP-6
SOURCE NOTE
FDA notes safety concerns, including effects on glucose regulation.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Glutathione
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Gonadorelin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →HCG
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →HGH 191AA
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →HMG
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Humanin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →IGF-1 LR3
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Ipamorelin
SOURCE NOTE
FDA flags gaps in safety information for some injectable routes.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Kisspeptin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →KPV
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →L-Carnitine
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Livagen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →LL-37
SOURCE NOTE
FDA describes safety uncertainties and concerning nonclinical findings.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Mazdutide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Melanotan I
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Melanotan II
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →MGF
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →MOTS-C
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →NAD+
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Ovagen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Oxytocin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →PE-22-28
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →PEG MGF
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Pinealon
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →PNC-27
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Prostamax
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →PT-141
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Retatrutide
SOURCE NOTE
FDA states retatrutide is not a component of an approved drug.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Selank
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Semaglutide
SOURCE NOTE
Approved and unapproved formulations are not interchangeable; verify the exact product and instructions.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Semax
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Sermorelin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →SLU-PP-332
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →SNAP-8
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →SS-31
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Survodutide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →TB-500
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Teriparatide
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Tesamorelin
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Testagen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Thymosin Alpha-1
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Tirzepatide
SOURCE NOTE
FDA has reported concerns about unapproved products and dosing errors.
Read the FDA source ↗Source checked November 5, 2026. Consult the linked page for updates and its exact scope.
Search PubMed for this name ↗How to evaluate what you find →Vesugen
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →Vilon
RESEARCH STARTING POINT
Use the original literature to investigate this name. Search results may include different formulations, laboratory findings and unrelated terminology. This entry does not summarize effectiveness or establish a safe regimen.
Search PubMed for this name ↗How to evaluate what you find →A name isn’t the whole story.
Learn to distinguish a promising finding from a reliable conclusion.